Meeting to be held in Austin and Dallas on May 1 hosted by BTIG.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RNAC:
- Seven new option listings and one option delisting on April 16th
- Buy Rating Affirmed for Cartesian Therapeutics Due to Promising Phase 2b Trial Results and Strong Safety Profile
- Promising Growth Potential for Cartesian Therapeutics: Buy Rating Affirmed by Analyst Gil Blum
- Promising Potential of Cartesian Therapeutics’ Descartes-08 in gMG Treatment: A Buy Recommendation
- Promising Clinical Data and Future Prospects Drive Buy Rating for Cartesian Therapeutics